893 related articles for article (PubMed ID: 21520094)
41. [Radiofrequency ablation for hepatocellular carcinoma and liver metastases].
Yasumoto T; Murakami T; Katsumoto Y; Hashimoto T; Noda S; Murata K; Kinuta M; Nakamura H
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1596-9. PubMed ID: 16315881
[TBL] [Abstract][Full Text] [Related]
42. Radiofrequency ablation versus hepatic resection for hepatocellular carcinoma within the Milan criteria--a comparative study.
Lai EC; Tang CN
Int J Surg; 2013; 11(1):77-80. PubMed ID: 23220487
[TBL] [Abstract][Full Text] [Related]
43. Surgical resection versus laparoscopic radiofrequency ablation in patients with hepatocellular carcinoma and Child-Pugh class a liver cirrhosis.
Santambrogio R; Opocher E; Zuin M; Selmi C; Bertolini E; Costa M; Conti M; Montorsi M
Ann Surg Oncol; 2009 Dec; 16(12):3289-98. PubMed ID: 19727960
[TBL] [Abstract][Full Text] [Related]
44. Outcomes of nontransplant potentially curative therapy for early-stage hepatocellular carcinoma in Child-Pugh stage A cirrhosis is comparable with liver transplantation.
Takahashi S; Kudo M; Chung H; Inoue T; Nagashima M; Kitai S; Tatsumi C; Minami Y; Ueshima K; Fukunaga T; Haji S
Dig Dis; 2007; 25(4):303-9. PubMed ID: 17960064
[TBL] [Abstract][Full Text] [Related]
45. Impact of radiofrequency ablation on the management of patients with hepatocellular carcinoma in a specialized centre.
Lam CM; Ng KK; Poon RT; Ai V; Yuen J; Fan ST
Br J Surg; 2004 Mar; 91(3):334-8. PubMed ID: 14991635
[TBL] [Abstract][Full Text] [Related]
46. Risk factors for distant recurrence of hepatocellular carcinoma in the liver after complete coagulation by microwave or radiofrequency ablation.
Izumi N; Asahina Y; Noguchi O; Uchihara M; Kanazawa N; Itakura J; Himeno Y; Miyake S; Sakai T; Enomoto N
Cancer; 2001 Mar; 91(5):949-56. PubMed ID: 11251946
[TBL] [Abstract][Full Text] [Related]
47. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis.
Raut CP; Izzo F; Marra P; Ellis LM; Vauthey JN; Cremona F; Vallone P; Mastro A; Fornage BD; Curley SA
Ann Surg Oncol; 2005 Aug; 12(8):616-28. PubMed ID: 15965731
[TBL] [Abstract][Full Text] [Related]
48. [Clinical evaluation of radiofrequency ablation therapy in patients with hepatic cavernous hemangiomas].
Fan RF; Chai FL; He GX; Li RZ; Wan WX; Bai MD; Zhu WK; Cao ML; Li HM; Yan SZ
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(23):1608-12. PubMed ID: 16185527
[TBL] [Abstract][Full Text] [Related]
49. Comparison of microwave ablation and radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis.
Tan W; Deng Q; Lin S; Wang Y; Xu G
Int J Hyperthermia; 2019; 36(1):264-272. PubMed ID: 30676100
[TBL] [Abstract][Full Text] [Related]
50. Results of single-probe microwave ablation of metastatic liver cancer.
Hompes R; Fieuws S; Aerts R; Thijs M; Penninckx F; Topal B
Eur J Surg Oncol; 2010 Aug; 36(8):725-30. PubMed ID: 20605397
[TBL] [Abstract][Full Text] [Related]
51. Efficacy of radiofrequency ablation therapy compared to surgical resection in 164 patients in Japan with single hepatocellular carcinoma smaller than 3 cm, along with report of complications.
Hiraoka A; Horiike N; Yamashita Y; Koizumi Y; Doi K; Yamamoto Y; Hasebe A; Ichikawa S; Yano M; Miyamoto Y; Ninomiya T; Otomi Y; Kokame M; Iwamura T; Ishimaru Y; Sogabe I; Kashihara K; Nishiura S; Ootani H; Takamura K; Kawasaki H
Hepatogastroenterology; 2008; 55(88):2171-4. PubMed ID: 19260499
[TBL] [Abstract][Full Text] [Related]
52. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection.
Kagawa T; Koizumi J; Kojima S; Nagata N; Numata M; Watanabe N; Watanabe T; Mine T;
Cancer; 2010 Aug; 116(15):3638-44. PubMed ID: 20564097
[TBL] [Abstract][Full Text] [Related]
53. Intraoperative radiofrequency ablation (RFA) for irresectable liver malignancies.
Tepel J; Hinz S; Klomp HJ; Kapischke M; Kremer B
Eur J Surg Oncol; 2004 Jun; 30(5):551-5. PubMed ID: 15135485
[TBL] [Abstract][Full Text] [Related]
54. Efficacy and tolerability of laparoscopic-assisted radiofrequency ablation of hepatocellular carcinoma in patients above 60 years of age.
Tesche LJ; Newton KN; Unger J; Semelka RC; Gerber DA
Surg Laparosc Endosc Percutan Tech; 2010 Dec; 20(6):404-9. PubMed ID: 21150419
[TBL] [Abstract][Full Text] [Related]
55. Liver resection and radiofrequency ablation of very early hepatocellular carcinoma cases (single nodule <2 cm): a single-center study.
Zhou Z; Lei J; Li B; Yan L; Wang W; Wei Y; Cheng K
Eur J Gastroenterol Hepatol; 2014 Mar; 26(3):339-44. PubMed ID: 24150522
[TBL] [Abstract][Full Text] [Related]
56. Limitation of repeated radiofrequency ablation in hepatocellular carcinoma: proposal of a three (times) × 3 (years) index.
Yokoyama K; Anan A; Iwata K; Nishizawa S; Morihara D; Ueda S; Sakurai K; Iwashita H; Hirano G; Sakamoto M; Takeyama Y; Irie M; Shakado S; Sohda T; Sakisaka S
J Gastroenterol Hepatol; 2012 Jun; 27(6):1044-50. PubMed ID: 22433056
[TBL] [Abstract][Full Text] [Related]
57. Radiofrequency ablation of hepatocellular carcinoma in cirrhotic patients.
Guglielmi A; Ruzzenente A; Battocchia A; Tonon A; Fracastoro G; Cordiano C
Hepatogastroenterology; 2003; 50(50):480-4. PubMed ID: 12749252
[TBL] [Abstract][Full Text] [Related]
58. Efficacy and safety of thermal ablation in patients with liver metastases.
Liu Y; Li S; Wan X; Li Y; Li B; Zhang Y; Yuan Y; Zheng Y
Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):442-6. PubMed ID: 23470267
[TBL] [Abstract][Full Text] [Related]
59. Radiofrequency vs Microwave Ablation After Neoadjuvant Transarterial Bland and Drug-Eluting Microsphere Chembolization for the Treatment of Hepatocellular Carcinoma.
Thornton LM; Cabrera R; Kapp M; Lazarowicz M; Vogel JD; Toskich BB
Curr Probl Diagn Radiol; 2017; 46(6):402-409. PubMed ID: 28392205
[TBL] [Abstract][Full Text] [Related]
60. Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.
Liu W; Zheng Y; He W; Zou R; Qiu J; Shen J; Yang Z; Zhang Y; Wang C; Wang Y; Zuo D; Li B; Yuan Y
Aliment Pharmacol Ther; 2018 Sep; 48(6):671-681. PubMed ID: 30063081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
